Castillo Jimeno J M, Illarramendi Mañas J J, Ruiz Rubio J L, Santiago González A, Sebastián Borruel J L
Servicio de Urología y Oncología, Hospital Virgen del Camino, Pamplona, Navarra, España.
Arch Esp Urol. 1991 Nov;44(9):1110-2.
We report on a patient with metastatic renal adenocarcinoma that had been detected following evaluation for monoclonal gammopathy associated with osteolytic lesions. When the foregoing associated conditions present, we must discard the presence of a myeloma. No objective data relating gammopathy with tumor behaviour are currently available.